Tech Company Financing Transactions

Neuros Medical Funding Round

North Coast Angel Fund, Glengary and Ohio TechAngels Fund participated in a $8 million Series A capital raise for Neuros Medical. The round was announced on 10/23/2009.

Transaction Overview

Company Name
Announced On
10/23/2009
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors

North Coast Angel Fund (Lead Investor) (Claiborne Rankin)

Glengary (Mark Teague)

Ohio TechAngels Fund

Queen City Angels

Proceeds Purpose
The company will utilize the funding to commence product development, expand its management team,and complete clinical studies.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
35010 Chardon Rd. 210
Willoughby Hills, OH 44094
USA
Email Address
Overview
Neuros Medical is focused on developing neurostimulation therapies for unmet needs to patients worldwide. The Company's platform technology, Nerve Block, provides patients with elimination of chronic pain and spasticity in a variety of applications including neuroma/residual limb pain with potential applications in cancer pain.
Profile
Neuros Medical LinkedIn Company Profile
Social Media
Neuros Medical Company Twitter Account
Company News
Neuros Medical News
Facebook
Neuros Medical on Facebook
YouTube
Neuros Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Wilder
  Thomas Wilder LinkedIn Profile  Thomas Wilder Twitter Account  Thomas Wilder News  Thomas Wilder on Facebook
Chief Operating Officer
David Veino
  David Veino LinkedIn Profile  David Veino Twitter Account  David Veino News  David Veino on Facebook
Chief Scientific Officer
Zi-Ping Fang
  Zi-Ping Fang LinkedIn Profile  Zi-Ping Fang Twitter Account  Zi-Ping Fang News  Zi-Ping Fang on Facebook
Founder
Jon Snyder
  Jon Snyder LinkedIn Profile  Jon Snyder Twitter Account  Jon Snyder News  Jon Snyder on Facebook
VP - Regulatory Affairs
Barbara Lindsay
  Barbara Lindsay LinkedIn Profile  Barbara Lindsay Twitter Account  Barbara Lindsay News  Barbara Lindsay on Facebook
VP - Regulatory Affairs
Melanie Parravi
  Melanie Parravi LinkedIn Profile  Melanie Parravi Twitter Account  Melanie Parravi News  Melanie Parravi on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/23/2009: Keraderm venture capital transaction
Next: 10/25/2009: Kabam venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary